Emine Göknur Işık

Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04

Serkan Kuyumcu, Bilal Kovan, Fikret Büyükkaya et al. · Clinical Nuclear Medicine · 2021 · 93 citations

Medicine, Nuclear Medicine, Oncology +17

Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results

Serkan Kuyumcu, Emine Göknur Işık, Tarık Onur Tiryaki et al. · Annals of Nuclear Medicine · 2021 · 36 citations

Medicine, Nuclear Medicine, Oncology +11

Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?

Duygu Has Şimşek, Caner Civan, Müge Nur Engin et al. · Annals of Nuclear Medicine · 2020 · 32 citations

Medicine, Nuclear Medicine, Radiology +16

Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to ΔSUVmax, Deauville 5-point scale and IHP criteria

Emine Göknur Işık, Serkan Kuyumcu, Rejin Kebudi et al. · Annals of Nuclear Medicine · 2017 · 28 citations

Medicine, Oncology, Radiology +11

68Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidism

Serkan Kuyumcu, Dilara Denizmen, Duygu Has Şimşek et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 27 citations · Full text

Medicine, Nuclear Medicine, Radiology +14